Bottom line
What is MCARX's expense ratio?
MCARX's expense ratio is 1.08%, or about $108 a year on every $10,000 invested. That is more expensive than 66% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Sep 25, 2026
MCARX fee table
| Net expense ratio | 1.08% |
|---|---|
| Gross expense ratio | 1.08% |
| Management fee | 0% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.09% |
| Acquired fund fees | 0.49% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Sep 25, 2026
What MCARX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MCARX | $110 | $343 | $595 | $1,317 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.08% expense ratio costs roughly $59,400 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).